Ocean(a)
Principal Investigator: Hari, Pawan, MD
Study Sponsor: Amgen
Location: Methodist Heart and Vascular Center
Phase of Study: Phase III
Purpose of study: There are currently no approved medications that directly target Lp(a) levels. That’s why we’re conducting the OCEAN(a) -PreEvent study. We want to find out if an investigational drug could help reduce the level of Lp(a) and learn about its effect on heart disease. This study could provide you with a chance to target a risk factor that is unable to be controlled with lifestyle changes and other medicines.
Inclusion Criteria:
– Are aged 50 and above
– Have a raised Lp(a) level
– Have a history of heart disease or are considered at risk of developing heart disease due to the presence of risk factors.
– Additional inclusion/exclusion criteria apply. Please contact the study team for more information.
Exclusion Criteria:
– Additional inclusion/exclusion criteria apply. Please contact the study team for more information.
Study Contact:
Darby Szabo
(651) 254-5344
Darby.A.Szabo@healthpartners.com
Study Flyer: